Sign in
4

Changes in Ownership

Cullinan Therapeutics, Inc. Filed Acc 0000950170-24-104820

Chief Scientific Officer sold 8,000 shares at $18.09 ($144,720)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Michaelson Jennifer Chief Scientific Officer 2024-09-05 Sale 10b5-1 −8,000 $18.09 $144,720 115,942 D: show line 1 in the form
Open-market sales · 8,000 sh · avg $18.09 · $144,720
Loading xslF345X05/ownership.xml…